Beta-adrenoceptor agonists block corticosteroid inhibition in eosinophils

American Journal of Respiratory and Critical Care Medicine
C P Nielson, N E Hadjokas

Abstract

Although beta-adrenoceptor agonists are primary agents in therapy of asthma, epidemiological studies have suggested that frequent or prolonged used of these drugs could be associated with exacerbation of disease. Mechanisms of any adverse effects remain unclear although in vitro studies have suggested that beta-adrenoceptor agonists can block glucocorticoid actions. Because asthma is an inflammatory disease characterized by eosinophil infiltration of the airways, actions of beta-agonists and corticosteroids that alter eosinophil survival and mediator generation may be of importance. Eosinophil generation of superoxide anion, a potent mediator that can damage respiratory epithelium, was markedly increased after 2-24 h of in vitro beta-adrenoceptor agonist exposure. These proinflammatory effects are in contrast to inhibition of superoxide generation, which is observed with acute beta-agonist exposure. Corticosteroid treatment to reduce inflammation is combined with beta-agonist therapy in current asthma guidelines. Although dexamethasone independently decreased eosinophil superoxide anion generation, in the presence of beta-adrenoceptor agonist dexamethasone inhibition was minimal and not statistically significant. Eosinophil sur...Continue Reading

References

Feb 20, 1992·The New England Journal of Medicine·W O SpitzerA S Rebuck
Mar 28, 1992·Lancet·J CraneC Burgess
Dec 23, 1992·JAMA : the Journal of the American Medical Association·P ErnstA S Buist
Oct 1, 1991·Australian and New Zealand Journal of Medicine·R BeasleyC Burgess
Jan 1, 1991·The Journal of Allergy and Clinical Immunology·H KitaG J Gleich
Jan 1, 1990·Free Radical Biology & Medicine·P J Barnes
Sep 25, 1995·Biochemical and Biophysical Research Communications·K ShindoM Fukumura
Apr 28, 1995·European Journal of Pharmacology·M J PetersP J Barnes
Dec 1, 1994·Current Opinion in Immunology·M C Seminario, G J Gleich
Jan 16, 1995·European Journal of Pharmacology·M M TeixeiraP G Hellewell
Jun 1, 1995·American Journal of Respiratory and Critical Care Medicine·K L WoolleyP M O'Byrne
Jan 7, 1995·Lancet·N PearceR Jackson
Jan 1, 1995·The Journal of Asthma : Official Journal of the Association for the Care of Asthma·H SugiyamaR G Townley
Mar 1, 1995·The Journal of Allergy and Clinical Immunology·N E HadjokasC P Nielson
Mar 1, 1994·American Journal of Respiratory and Critical Care Medicine·S SuissaW O Spitzer
Sep 1, 1995·Thorax·J CraneR Beasley
Sep 1, 1995·Thorax·D R Taylor, C S Wong

❮ Previous
Next ❯

Citations

Oct 27, 2009·Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology·Christine J van DalenAnthony J Kettle
Jun 26, 2001·Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology·F M SpoelstraH F Kauffman
Oct 7, 2000·Respirology : Official Journal of the Asian Pacific Society of Respirology·R OzarasA Cetinkaya
Jan 6, 2000·Journal of Aerosol Medicine : the Official Journal of the International Society for Aerosols in Medicine·D Pavia, D Moonen
Nov 6, 2009·Current Opinion in Pulmonary Medicine·Nicola A HananiaRichard A Bond
Jun 17, 2000·Thorax·D R Taylor, R J Hancox
May 12, 2000·American Journal of Respiratory and Critical Care Medicine·R E AldridgeG I Town
Oct 13, 2000·American Journal of Respiratory and Critical Care Medicine·F M SpoelstraD S Postma
Jul 5, 2001·BioDrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy·R J Hancox, D R Taylor
Aug 1, 2000·Cellular Immunology·H S ChangC S Park
Mar 24, 2010·Pulmonary Pharmacology & Therapeutics·Karin StrandbergKjell Larsson
Sep 26, 2000·Pulmonary Pharmacology & Therapeutics·M A GiembyczM A Lindsay
Jul 11, 2000·The Journal of Allergy and Clinical Immunology·V A SwystunD W Cockcroft
Nov 24, 1999·Critical Reviews in Clinical Laboratory Sciences·G M Walsh
Apr 2, 2010·Allergy, Asthma & Immunology Research·Yong Mean Park, Bruce S Bochner
Jan 9, 2003·Expert Opinion on Pharmacotherapy·Luis García-MarcosNicolás Cobos Barroso
May 29, 2020·The Korean Journal of Internal Medicine·Youngwoo ChoiHae-Sim Park
Jan 12, 2000·The Annals of Pharmacotherapy·K V Blake
May 18, 1999·The Journal of Allergy and Clinical Immunology·B Waldeck

❮ Previous
Next ❯

Related Concepts

Related Feeds

Anti-inflammatory Treatments

A drug or substance that reduces inflammation (redness, swelling, and pain) in the body. Anti-inflammatory agents block certain substances in the body that cause inflammation and swelling. Discover the latest research on anti-inflammatory treatments here

Asthma

This feed focuses in Asthma in which your airways narrow and swell. This can make breathing difficult and trigger coughing, wheezing and shortness of breath.

Adrenergic Receptors: Trafficking

Adrenergic receptor trafficking is an active physiological process where adrenergic receptors are relocated from one region of the cell to another or from one type of cell to another. Discover the latest research on adrenergic receptor trafficking here.

Allergy and Asthma

Allergy and asthma are inflammatory disorders that are triggered by the activation of an allergen-specific regulatory t cell. These t cells become activated when allergens are recognized by allergen-presenting cells. Here is the latest research on allergy and asthma.

American Thoracic Association Journals

Discover the latest respiratory research published by the journals from the American Thoracic Society.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis